Oxidative stress in cystic fibrosis: does it occur and does it matter?
van der Vliet
A
A
Division of Pulmonary and Critical Care Medicine, University of California Davis Medical Center, Sacramento 95817, USA.
Eiserich
J P
JP
Marelich
G P
GP
Halliwell
B
B
Cross
C E
CE
D000280:Administration, Inhalation; D001205:Ascorbic Acid / Q000008:administration & dosage / Q000627:therapeutic use; D003550:Cystic Fibrosis / Q000188:drug therapy / Q000378:metabolism* / Q000473:pathology; D006801:Humans; D008171:Lung Diseases / Q000378:metabolism / Q000473:pathology; D009569:Nitric Oxide / Q000378:metabolism; D018384:Oxidative Stress; D017382:Reactive Oxygen Species; D013438:Sulfhydryl Compounds / Q000008:administration & dosage / Q000627:therapeutic use; D014132:Trachea / Q000378:metabolism / Q000473:pathology; D019207:beta Carotene / Q000172:deficiency
D017382:Reactive Oxygen Species; D013438:Sulfhydryl Compounds; D019207:beta Carotene; D009569:Nitric Oxide; D001205:Ascorbic Acid